Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Clinical Research (Excluding Clinical Trials)

Abstract LB-052: Using community team science: An advocacy engaged approach to recruit ethnic minorities in cancer research

Kimlin Ashing, Mayra Serrano, Steve Rosen, Marisela Huerta, Katty Nerio, Alejandro Fernandez, Lisa Dowd, Phyllis Clark, Lucy Young, Mary Ann Van Duyen and Precilla Belin
Kimlin Ashing
City of Hope, Duarte, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mayra Serrano
City of Hope, Duarte, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Rosen
City of Hope, Duarte, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marisela Huerta
City of Hope, Duarte, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katty Nerio
City of Hope, Duarte, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro Fernandez
City of Hope, Duarte, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Dowd
Duarte Unified School District, Duarte, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phyllis Clark
Healthy Heritage, Riverside, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucy Young
Herald Cancer Association, San Gabriel, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Ann Van Duyen
National Cancer Institute, Bethesda, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Precilla Belin
National Cancer Institute, Bethesda, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2017-LB-052 Published July 2017
  • Article
  • Info & Metrics
Loading
Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC

Abstract

The inclusion of medically vulnerable population in research is required to improve population health. Ethnic Minorities are among the most medically underserved, and represent 40% of the US population. Hence, ethnic minority inclusion in biomedical research is essential to ensure optimal applicability and benefit of medical advancements. Informed by the Community Health Educator (CHE) program of the NCI-CRCHD and charged by our Cancer Center goal to reduce the burden of cancer within our Catchment area communities, we created and tested our Partnered for Inclusion and Access in Research (PAIR) model to increase community responsiveness and minority participation in our research. First, using a team science community engaged approach, our research institute – including basic, translational, clinical and population researchers – aligned with our clinical care, hospital component to form a common Community Advisory Council (CAC). The CAC enhances the integrated representation of the community’s voice within our research and practice. Our CAC, therefore, serves as a resource in reaching other community advisors for targeted research and community benefit programs. For example, our CAC facilitated the inclusion of African American, Chinese and Latino communities for our U01 project investigating breast cancer and the environment. Secondly, in collaboration with community partners including ACS, we are training community research navigators to broaden our reach, and increase community capacity to engage with researchers and participate in research, as well as address their pressing health concerns. Thirdly, we created a culturally and linguistically tailored brief video promoting Latino participation in clinical trials (CT), biospecimen studies (BB) and population research. This video is used in combination with direct referral to a research study with the intent of increasing awareness, acceptability, access and participation of Latinos in CT, BB and population research. Our report focusing on a BB study with Latinas, show that, to date a total of 372 women were accrued resulting in an 88% BB enrollment. Therefore, our community engaged, culturally and linguistically appropriate PAIR model demonstrates utility and effectiveness in engaging ethnic minorities and in particular Latinos in biomedical research. Future plans include continued, expanded face-to-face and technology platform dissemination of PAIR.

Citation Format: Kimlin Ashing, Mayra Serrano, Steve Rosen, Marisela Huerta, Katty Nerio, Alejandro Fernandez, Lisa Dowd, Phyllis Clark, Lucy Young, Mary Ann Van Duyen, Precilla Belin. Using community team science: An advocacy engaged approach to recruit ethnic minorities in cancer research [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr LB-052. doi:10.1158/1538-7445.AM2017-LB-052

  • ©2017 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 77 (13 Supplement)
July 2017
Volume 77, Issue 13 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract LB-052: Using community team science: An advocacy engaged approach to recruit ethnic minorities in cancer research
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract LB-052: Using community team science: An advocacy engaged approach to recruit ethnic minorities in cancer research
Kimlin Ashing, Mayra Serrano, Steve Rosen, Marisela Huerta, Katty Nerio, Alejandro Fernandez, Lisa Dowd, Phyllis Clark, Lucy Young, Mary Ann Van Duyen and Precilla Belin
Cancer Res July 1 2017 (77) (13 Supplement) LB-052; DOI: 10.1158/1538-7445.AM2017-LB-052

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract LB-052: Using community team science: An advocacy engaged approach to recruit ethnic minorities in cancer research
Kimlin Ashing, Mayra Serrano, Steve Rosen, Marisela Huerta, Katty Nerio, Alejandro Fernandez, Lisa Dowd, Phyllis Clark, Lucy Young, Mary Ann Van Duyen and Precilla Belin
Cancer Res July 1 2017 (77) (13 Supplement) LB-052; DOI: 10.1158/1538-7445.AM2017-LB-052
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Clinical Research (Excluding Clinical Trials)

  • Abstract LB-250: Liquid biopsy in NSCLC: EpCAM+ and EpCAM- circulating tumor cells, tumor derived extracellular vesicles and cell-free circulating tumor DNA
  • Abstract LB-239: Pharmacodynamic changes confirm the mechanism of action mediating SD-101 efficacy, in combination with pembrolizumab, in a phase 1b/2 study in metastatic melanoma (MEL-01)
  • Abstract LB-249: Examination of analytical factors impacting concordance of plasma-tumor testing by next-generation sequencing (NGS)
Show more 3

Poster Presentations - Late-Breaking Abstracts

  • Abstract LB-321: Cytoplasmic DEDD promotes G1- to S-phase cell cycle transition
  • Abstract LB-301: PLK1 inhibitor targets mismatch repair-deficient temozolomide-resistant tumors
  • Abstract LB-334: xCT promotes malignant phenotypes in EGFR-expressing glioma
Show more 3

Poster Presentations - Late-Breaking Research: Clinical Research 1

  • Abstract LB-059: Neoadjuvant immunotherapy with androgen deprivation therapy (ADT) prior to radiation in prostate cancer: Impact on multiparametric prostate MRI and immune responses
  • Abstract LB-048: Impact of KIR/KIR ligand genotype for neuroblastoma patients in a Phase 3 COG immunotherapy trial
  • Abstract LB-038: Preclinical development and clinical validation of a whole blood pharmacodynamic marker assay for the BET bromodomain inhibitor ZEN-3694 in metastatic castration-resistant prostate cancer (mCRPC) patients
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement